DermAbiotech Sàrl
Innovative targeted therapies for acute T cell-mediated inflammatory diseases
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
DermAbiotech Sàrl
Innovative targeted therapies for acute T cell-mediated inflammatory diseases
Headquarter:
Plan-les-Ouates
Foundation Date:
October 2014
Technology:
- Biotech
Sectors:
- Biotech
Support received
